Format

Send to

Choose Destination
Adv Chronic Kidney Dis. 2017 Sep;24(5):315-318. doi: 10.1053/j.ackd.2017.06.004.

Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes.

Author information

1
Division of Nephrology, Department of Medicine, University of Utah, Salt Lake City, UT; and Nephrology Section, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT.
2
Division of Nephrology, Department of Medicine, University of Utah, Salt Lake City, UT; and Nephrology Section, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT. Electronic address: kalani.raphael@hsc.utah.edu.

Abstract

Abnormalities of serum potassium are common in patients with CKD. Although hyperkalemia is a well-recognized complication of CKD, the prevalence rates of hyperkalemia (14%-20%) and hypokalemia (12%-18%) are similar. CKD severity, use of medications such as renin-angiotensin-aldosterone system inhibitors and diuretics, and dietary potassium intake are major determinants of serum potassium concentration in CKD. Demographic factors, acid-base status, blood glucose, and other comorbidities contribute as well. Both hyperkalemia and hypokalemia are associated with similarly increased risks of death, cardiovascular disease, and hospitalization. On the other hand, limited evidence suggests a link between hypokalemia, but not hyperkalemia, and progression of CKD. This article reviews the prevalence rates and risk factors for hyperkalemia and hypokalemia, and their associations with adverse outcomes in CKD.

KEYWORDS:

Chronic kidney disease; Hyperkalemia; Hypokalemia; Outcomes; Potassium

PMID:
29031358
DOI:
10.1053/j.ackd.2017.06.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center